Leukemia drug shows the potential to treat aggressive pediatric brain câncer
IMAGE: A) Arsenic Trioxide (ATO) reduces the clonogenic capacity of medulloblastoma (MB) cell lines of the SHH subgroup (DAOY: TP53 c.725G>T; UW402: TP53 c.464C>A and ONS-76: TP53 wild type). B) Clonogenic... view more Credit: Paulo Henrique dos Santos Klinger By André Julião | Agência FAPESP – Researchers affiliated with the University…
bubmagJuly 21, 2020